YANTAI, China, May 12, 2025 /PRNewswire/ -- On May 12th, 2025, RemeGen Co., Ltd. ("RemeGen", stock symbols: 688331.SH/09995.HK) announced that its phase 3 clinical trial (Study ID: RC48-C016) on ...

A phase converter provides three-phase power from a single-phase ... Be sure to take pictures and draw a diagram listing all connections that were undone. Making space for removal of the capacitor ...

The phase 3 trial enrolled 1033 patients who had not received prior chemotherapy for mCRPC and had evidence of disease progression despite androgen deprivation therapy (ADT). Study participants ...

announced today they have successfully completed enrollment in their phase 2a study, which will evaluate ZetaMet™ (Zeta-BC-003) in the treatment of spinal metastatic lytic breast cancer lesions ...

Demonstrating statistically significant increases in both median overall survival and percent of patients reaching one-year survival and beyond, along with a favorable risk-benefit profile in this ...

Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer Delcath Systems, Inc. (NASDAQ: DCTH), an ...

April 17, 2025 /PRNewswire/ -- Endevica Bio, a privately held company developing first-in-class peptide drug candidates, announced today the dose administration for the first patient in a Phase 2 ...

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced results from an expansion cohort of the phase 1b/2 STELLAR-001 trial evaluating zanzalintinib alone or in ...

Flexibility is key — view retirement as a dynamic journey rather than a static phase.” He also urged retirees not to underestimate the importance of nonfinancial aspects of retirement ...

A phase 3 study is planned to compare alisertib plus endocrine therapy with placebo, following optimal dose determination in phase 2. A phase 2 study for patients with HR-positive, HER2-negative ...